Anti-Inflammatory Drugs Market to Reach USD 175.97 Billion by 2030; Demand Driven by Chronic Disease Growth and Broader OTC Access

Introduction: 

The anti-inflammatory drugs market is a key segment of the global pharmaceuticals industry focused on therapies that reduce inflammation linked to conditions such as arthritis, COPD, tendonitis and other chronic disorders. According to the latest analysis by Mordor Intelligence, the market is expected to expand significantly between 2025 and 2030, with revenue rising from around USD 120.37 billion in 2025 to approximately USD 175.97 billion by 2030, reflecting a compound annual growth rate of 7.89 %. This growth is supported by demographic shifts like aging populations, increasing incidence of chronic inflammatory diseases, and improvements in drug accessibility, including the switch of some therapies from prescription to over-the-counter channels. 

Key Trends: 

• Rising prevalence of chronic inflammatory diseases 

• Increased adoption of biologics 

• Expansion of over-the-counter NSAIDs 

• Growing use of JAK inhibitors 

• API supply constraints 

• Regulatory scrutiny on long-term NSAID use 

Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights:  https://www.mordorintelligence.com/ja/industry-reports/anti-inflammatory-drugs-market?utm_source=Industrytoday.co.uk 

Market Segmentation 

By Application  

• Arthritis  
• Chronic Obstructive Pulmonary Disease (COPD)  
• Multiple Sclerosis  
• Inflammatory Bowel Disease (IBD)  
• Asthma  
• Tendonitis  
• Other Applications  

By Drug Class  

• Anti-Inflammatory Biologics  
• Non-steroidal Anti-Inflammatory Drugs (NSAIDs)  
• Corticosteroids  
• Immune-selective Anti-inflammatory Derivatives (ImSAIDs)  
• Other Drug Classes  

By Route of Administration  

• Oral  
• Parenteral  
• Topical  
• Inhalation  

By Sales Channel  

• Prescription  
• Over the Counter (OTC) 

Geography Analysis: 

The United States remains the most significant market for anti-inflammatory drugs, supported by advanced healthcare infrastructure, strong clinical research activity, and wide insurance coverage for innovative and established therapies. High adoption rates for biologics and newer targeted treatments contribute to robust revenue generation. Regulatory support for expanding access to non-prescription anti-inflammatory treatments also broadens the patient base. 

Explore Our Full Library of Healthcare Research Industry Reports - https://www.mordorintelligence.com/market-analysis/healthcare?utm_source=Industrytoday.co.uk 

Industry Related Reports: 

SGLT2 Market - https://www.mordorintelligence.com/industry-reports/sglt-2-market?utm_source=Industrytoday.co.uk

Immunosuppressant Drugs Market - https://www.mordorintelligence.com/industry-reports/immunosuppressant-drugs-market?utm_source=Industrytoday.co.uk 

Antipsychotic Drugs Market - https://www.mordorintelligence.com/industry-reports/antipsychotic-drugs-market?utm_source=Industrytoday.co.uk 

About Mordor Intelligence: 

Mordor Intelligence is a trusted partner for businesses seeking actionable market insights. With 550+ domain experts and specialists across 150+ countries, we deliver comprehensive syndicated and custom research across industries such as aerospace, agriculture, chemicals, consumer goods, energy, healthcare, and many more, helping organizations make informed decisions and achieve strategic goals. 

For any inquiries or to access the full report, please contact: 

media@mordorintelligence.com 

https://www.mordorintelligence.com/